Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exenatide for Myocardial Protection During Reperfusion Study (EMPRES)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by University Health Network, Toronto
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Vladimír Džavík, University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT01938235
First received: August 29, 2013
Last updated: August 3, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)